Trials / Completed
CompletedNCT01692964
Clinical Evaluation of the InflammaDry Device for Detecting Dry Eye
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 237 (actual)
- Sponsor
- Rapid Pathogen Screening · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
InflammaDry is a rapid diagnostic test for the detection of elevated levels of Matrix Metalloproteinase-9 (MMP-9) protein in tear fluid.
Detailed description
The InflammaDry test will be used to aid in the diagnosis of dry eye in conjunction with other methods of clinical evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | InflammaDry | A noninvasive immunoassay for detecting MMP-9 levels in tears. |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2012-09-26
- Last updated
- 2020-10-12
- Results posted
- 2020-10-12
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01692964. Inclusion in this directory is not an endorsement.